List of Pharma Stocks in India in 2025
India has solidified its position as the world’s largest supplier of generic medicines, fulfilling approximately 20% of global generic drug exports. The nation’s pharmaceutical exports reached $27 bn in 2023, a significant increase from $19 bn in 2018, growing at an annual rate of 8%. Domestically, the Indian pharmaceutical market is projected to expand by 8.2% in 2025, reaching ₹2.38 lakh cr. This article will look at the top pharmaceutical companies in India, including benefits, risks, and factors to consider before investing in them.
Top Pharma Stocks
Friday, 29 August, 2025
| symbol | Company | ticker | slug | Sector | Market Price | 52W High | 52W Low | Market Cap (Cr.) | PE Ratio | Industry PE | PB Ratio | Div. Yield (%) | ROE (%) | 1YReturns | 3YReturns | 5YReturns | Market Cap Label | Industry Group | Industry | Sub Industry | percentageChange |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABOT | Abbott India Ltd | ABBOTINDIA | /stocks/abbott-india-ABOT | Pharmaceuticals | 31,475.00 | 37,000.00 | 25,325.00 | 67,773.51 | 47.92 | 36.72 | 16.01 | 1.49 | 35.66 | 5.07 | 67.72 | 87.17 | Midcap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | 1.05 |
| ALKE | Alkem Laboratories Ltd | ALKEM | /stocks/alkem-laboratories-ALKE | Pharmaceuticals | 5,376.00 | 6,439.90 | 4,491.65 | 64,847.39 | 29.95 | 36.72 | 5.22 | 0.83 | 18.71 | -10.36 | 84.63 | 87.09 | Midcap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | -1.22 |
| CADI | Zydus Lifesciences Ltd | ZYDUSLIFE | /stocks/cadila-healthcare-CADI | Pharmaceuticals | 978.60 | 1,159.35 | 795.00 | 99,430.33 | 21.97 | 36.72 | 3.77 | 1.11 | 18.68 | -14.03 | 159.27 | 151.67 | Largecap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | 0.42 |
| CIPL | Cipla Ltd | CIPLA | /stocks/cipla-CIPL | Pharmaceuticals | 1,580.30 | 1,702.05 | 1,335.00 | 127,646.87 | 24.21 | 36.72 | 4.08 | 1.01 | 18.15 | -2.34 | 55.34 | 111.10 | Largecap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | 0.77 |
| LUPN | Lupin Ltd | LUPIN | /stocks/lupin-LUPN | Pharmaceuticals | 1,902.40 | 2,402.90 | 1,795.20 | 87,933.07 | 26.80 | 36.72 | 5.08 | 0.62 | 20.73 | -13.56 | 187.39 | 94.90 | Midcap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | -0.01 |
| MANKI | Mankind Pharma Ltd | MANKIND | /stocks/mankind-pharma-MANKI | Pharmaceuticals | 2,474.10 | 3,054.80 | 2,115.10 | 103,272.17 | 51.87 | 36.72 | 7.09 | 0.00 | 16.49 | 1.88 | 73.95 | 73.95 | Largecap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | 0.47 |
| SUN | Sun Pharmaceutical Industries Ltd | SUNPHARMA | /stocks/sun-pharmaceutical-industries-SUN | Pharmaceuticals | 1,585.70 | 1,960.35 | 1,553.05 | 384,079.56 | 35.14 | 36.72 | 5.30 | 1.00 | 15.66 | -12.48 | 80.35 | 185.33 | Largecap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | 0.39 |
| TORP | Torrent Pharmaceuticals Ltd | TORNTPHARM | /stocks/torrent-pharmaceuticals-TORP | Pharmaceuticals | 3,576.90 | 3,787.90 | 2,886.45 | 122,039.03 | 63.85 | 36.72 | 16.08 | 0.89 | 26.46 | 4.60 | 132.05 | 164.04 | Largecap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | -0.19 |
Disclaimer: Please note that the above list is for educational purposes only, and is not recommendatory. Please do your own research or consult your financial advisor before investing.
Note: The data on this pharma stocks screener is dynamic in nature and subject to real-time changes. This data is derived from Tickertape Stock Screener.
Readymade Model Portfolios in the Pharma Sector
The Pharma Tracker smallcase, managed by Windmill Capital, comprises pharmaceutical and life sciences companies in NSE,
Disclosures for the Pharma Tracker smallcase.
The Pharma Select Tracker smallcase, managed by Green Portfolio, is a portfolio that taps into India’s booming pharma sector, featuring 10-12 top companies.
Disclosures for the Pharma Select Tracker smallcase.
What are Pharma Stocks in India?
Pharma stocks in India represent shares of companies that work in the pharmaceutical sector. These companies focus on researching, developing, manufacturing, and distributing drugs and medicines. Leading pharma firms produce prescription drugs, over-the-counter medicines, and generic drugs.
What is the Pharma NIFTY Index?
The Pharma NIFTY Index is a stock market index on the National Stock Exchange of India (NSE) that tracks the performance of leading pharmaceutical companies listed on the exchange. NSE selects these pharma stocks based on factors like market capitalisation and liquidity. This index acts as a benchmark to measure how the Indian pharmaceutical sector is performing overall.
Abput the Top Pharma Stocks
- Sun Pharmaceutical Industries Ltd: Sun Pharma is India’s largest pharmaceutical company and a global leader in generic medicines. It produces a wide range of drugs across therapeutic areas.
- Cipla Ltd: Cipla is a major Indian pharmaceutical firm known for its focus on respiratory, HIV/AIDS, and chronic disease medicines. The company manufactures affordable healthcare solutions and has a strong presence in both domestic and global markets.
- Torrent Pharmaceuticals Ltd: Torrent Pharma specialises in therapies like cardiovascular, central nervous system, gastrointestinal, and anti-infective.
- Dr Reddy’s Laboratories Ltd: Dr Reddy’s is a global pharmaceutical company offering generic medicines, biosimilars, and active pharmaceutical ingredients.
- Mankind Pharma Ltd: Mankind Pharma is known for its wide product portfolio in antibiotics, gastrointestinal, and reproductive health.
How to Invest in Pharma Stocks?
Here is how one can invest in the best pharma stocks in India:
- Open a demat/trading/stockbroker account. You can open ademat account with smallcase!
- Conduct thorough research into the pharma stocks in 2025 that are of interest to you. Investors can use tools like the Tickertape Stock Screener to do this. The screener offers 200+ built-in filters to choose from, and investors can choose the parameters to research a list of pharma shares.
- Place a ‘Buy’ Order on the pharma stocks of your choosing.
Budget Update on Healthcare Sector for 2025-26
In the Union Budget for FY 2025–26, Finance Minister Nirmala Sitharaman allocated ₹98,311 crore to the healthcare sector, marking a 10.11% rise from the previous year. The announcement included several pharmaceutical initiatives:
- The government fully exempted 36 life-saving drugs for cancer and other chronic or rare diseases from customs duty.
- It applied a reduced 5% customs duty on six life-saving medicines.
- Under the Patient Assistance Programme, 37 more medicines and 13 new support schemes were added.
Latest Updates in the Indian Pharma Sector
- Global Pharma Outsourcing Boom: International pharmaceutical companies are increasingly outsourcing drug development and manufacturing to cost-efficient Indian CDMOs.
- Aggressive Capacity Expansion: Indian firms are investing in new facilities and scaling up operations to meet rising global demand.
- Strong Regulatory Compliance: These pharma companies meet global quality standards, allowing them to serve major clients across the US, Europe, and other regulated markets.
- Shift Toward Complex & High-Value Drugs: Indian CDMOs are expanding into areas like biologics, speciality generics, and advanced formulations to boost future growth.
Benefits of Investing in Pharma Stocks in India
- Global Export Demand: India supplies nearly 20% of global generic medicines and ranks among the top exporters of pharmaceuticals. This global presence offers pharma companies a steady revenue stream and exposure to international markets
- Steady Demand: Pharma stocks are known for their steady demand, as people require medicines regardless of the economic climate. This makes them less volatile compared to cyclical sectors.
- Government Backing: Initiatives like the Production Linked Incentive (PLI) scheme and bulk drug parks strengthen the domestic supply chain and reduce import dependence, benefiting Indian pharma sector stocks.
- Exposure to Healthcare Growth: Pharma companies benefit directly from India’s expanding healthcare ecosystem, which includes increased insurance penetration, hospital expansion, and government initiatives such as Ayushman Bharat.
Risks of Investing in Pharma Stocks in India
- Regulatory Environment: The pharmaceutical industry operates under heavy regulations, and changes in government policies, especially regarding price controls and exports, can directly affect even the top pharmaceutical companies in India.
- High R&D Costs and Uncertainty: While R&D is critical for growth, it is capital-intensive and risky. Many drug development projects fail at late stages, leading to sunk costs without assured returns.
- Currency Fluctuations and Operational Risks: The export-oriented nature of the Indian pharma industry in India makes it susceptible to currency fluctuations, directly impacting revenues and the bottom line.
- Competition Pressure: Intense domestic and global competition in generics and biosimilars pushes prices down, making it harder for companies to maintain margins.
Factors to Consider Before Investing in Pharma Companies
- Domestic and Global Demand: Pharma stocks’ growth potential depends on demand in domestic and global markets. The demand is often influenced by factors like an ageing population, increasing healthcare spending and diseases.
- Regulatory Environment and Government Policies: It’s essential to stay informed about regulatory changes and procedures that impact the industry and individual pharmaceutical companies’ stocks.
- Intellectual Property Rights and Patent Expirations: Patents give pharma companies the right to manufacture and sell a drug for a specific period. Checking a company’s patent portfolio and patent expirations can help to understand its impact on revenue.
- Competition, Mergers and Acquisitions: Evaluating a company’s competitive edge, growth strategies, and recent mergers or acquisitions can provide insights into its potential for long-term success.
Can't decide which stocks to pick?
smallcase offers 500+ readymade stock baskets, created and managed by SEBI-registered investment experts
Try smallcase
smallcases are readymade model portfolios of stocks/ETFs, that are based on a theme, idea or strategy. They’re created and managed by SEBI-registered investment experts (also known as smallcase managers).
Among the 500+ expert-curated portfolios, here are a few popular smallcases among new investors:
Disclosures for aforementioned smallcases
To Wrap It Up…
Pharma stocks in India represent a sector that combines global demand, domestic healthcare needs, and innovation-driven growth. With India recognised as the “pharmacy of the world,” companies continue to play a critical role in generics, formulations, and exports. At the same time, regulatory challenges, pricing pressures, and global competition are the key factors that determine pharma stocks’ growth potential.
Discover ready-made stock baskets on smallcase
smallcase offers simple, quick & delightful investing for you with 200+ readymade stock baskets, created and managed by SEBI-registered investment experts
Frequently Asked Questions on Pharma Stocks
1. How can I invest in Indian pharma sector stocks?
To invest in the best pharma stocks in 2025, you need to:
- Open a brokerage account using smallcase
- Research pharmaceutical companies on Tickertape using various filters
- Place buy orders for selected stocks, and monitor your investments.
2. Is it a good time to explore pharma stocks?
The suitability of investing in pharma stocks depends on market conditions and your financial goals. Evaluating factors like the pharmaceutical industry’s performance and company-specific data, and consulting a financial advisor can help investors to make the right decision.
3. What should I look for in pharmaceutical stocks?
When evaluating the best pharma stocks in India, it’s important to keep track of factors like a strong drug pipeline, successful regulatory approvals, steady financial performance, and investment in R&D.
4. Are pharma stocks risky?
Pharma stocks carry certain risks linked to regulatory approvals, patent expiries, global pricing pressures, and heavy R&D expenses. Market competition and policy changes can also affect their performance, leading to fluctuations in stock prices.
5. What is the dividend yield of pharma stocks?
Pharma stocks’ dividend yield depends on the individual company’s financial performance, cash reserves, and dividend policy. Some established pharmaceutical firms offer consistent dividends, while others reinvest earnings into R&D and expansion. Investors can use Tickertape to find the dividend yield of each pharma company and make informed decisions.
6. What should be the investment strategy for investing in pharma stocks?
There is no single pharma stock investment strategy that fits all. The strategy often varies depending on company fundamentals, research pipelines, export markets, and regulatory frameworks. Some pharma stocks focus on R&D, while others focus on steady cash flows and dividends.
Explore the Popular Stock Collections:
Thematic Stocks:
Keep yourself informed and up-to-date on a variety of thematic sectors by reading the articles below:
Indices and Market Movers:
Stocks Under Budget:
If you are looking for stocks under a particular price range, here’s the collection of stocks under a specifc budget:
